Search Results - "Vynck, M."

A single dose of intravenous combretastatin A4‐phosphate is reasonably well tolerated and significantly reduces tumour vascularization in canine spontaneous cancers by Abma, E., De Spiegelaere, W., Vanderperren, K., Stock, E., Van Brantegem, L., Cornelis, I., Daminet, S., Ni, Y., Vynck, M., Verstraete, G., Smets, P., de Rooster, H.

“…Combretastatin A4‐phosphate (CA4P) is an anti‐tumour vascular targeting agent which selectively blocks tumour blood flow. Research on CA4P in rodent tumour…”
Get full text

Single vitrified blastocyst transfers using an aseptic microdroplet vitrification-warming system: live birth rate is determined by expansion rate on day 5 and influenced by morphological quality by Gunst, J., Vynck, M., Hostens, K., Standaert, V., Roggeman, S., Van De Vijver, A.

Get full text

The occurrence and therapeutic consequences of androgen receptor copy number gain in prostate cancer patients using Droplet Digital PCR by Buelens, S, Claeys, T, Kumps, C, Dhondt, B, Poelaert, F, Nurten, Y, Vynck, M, Thas, O, Ost, P, Vandesompele, J, Lumen, N

Get full text

486 - The occurrence and therapeutic consequences of androgen receptor copy number gain in prostate cancer patients using Droplet Digital PCR by Buelens, S., Claeys, T., Kumps, C., Dhondt, B., Poelaert, F., Nurten, Y., Vynck, M., Thas, O., Ost, P., Vandesompele, J., Lumen, N.

Get full text